Nucleic Acid–based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia
May 1, 2021
Last Updated Month/Year
August 15, 2023
Supplemental Implementation Tools
Country of Publication
This document provides evidence-based clinical practice guidelines on the diagnostic utility of nucleic acid–based testing of respiratory samples for viral pathogens other than influenza in adults with suspected community-acquired pneumonia (CAP).
Male, Female, Adolescent, Adult, Child, Infant, Older adult
Health Care Settings
Ambulatory, Hospital, Laboratory services
Nurse, nurse practitioner, physician, physician assistant
Diagnosis, Assessment and screening
D011014 - Pneumonia, D021141 - Nucleic Acid Amplification Techniques
community-acquired pneumonia, pneumonia, nucleic acid amplification test (NAAT), NAAT
Evans SE, Jennerich AL, Azar MM, Cao B, Crothers K, Dickson RP, Herold S, Jain S, Madhavan A, Metersky ML, Myers LC, Oren E, Restrepo MI, Semret M, Sheshadri A, Wunderink RG, Dela Cruz CS. Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2021 May 1;203(9):1070-1087. doi: 10.1164/rccm.202102-0498ST. PMID: 33929301; PMCID: PMC8314899.